Sleep Disorder

Sleep disorders are a class of conditions involving persistent disruption of normal sleep patterns, sufficient to cause distress and impair daytime functioning. The DSM-5-TR includes insomnia, hypersomnolence, narcolepsy, sleep-related breathing disorders, parasomnias, and circadian rhythm sleep-wake disorders.

Overview

Sleep disorders are a class of conditions characterized by persistent disruption of normal sleep patterns sufficient to cause significant distress or impair daytime functioning. The DSM-5-TR Sleep-Wake Disorders chapter includes ten disorders: Insomnia Disorder (780.52), Hypersomnolence Disorder (780.54), Narcolepsy (347.0), Breathing-Related Sleep Disorders (obstructive sleep apnea hypopnea, central sleep apnea, sleep-related hypoventilation), Circadian Rhythm Sleep-Wake Disorders, Non-Rapid Eye Movement Sleep Arousal Disorders (sleepwalking, sleep terrors), Nightmare Disorder, Rapid Eye Movement Sleep behaviour Disorder, Restless Legs Syndrome, and substance/medication-induced sleep disorder.

Sleep disorders are extraordinarily common. Insomnia affects approximately 10-30% of adults at any given time, with chronic insomnia (3+ nights per week for 3+ months) affecting approximately 6-10% of the population. Obstructive sleep apnea affects approximately 9-25% of middle-aged adults (often undiagnosed). Restless legs syndrome affects 5-10% of adults. Circadian rhythm disorders are common in shift workers, adolescents, and individuals with significant time-zone travel.

Sleep disorders are bidirectionally related to mental health. Sleep disturbance is a symptom of most psychiatric conditions and a risk factor for their onset and worsening. Untreated insomnia is one of the strongest predictors of new-onset major depressive disorder. Conversely, treatment of sleep disorders frequently produces meaningful improvement in mood, anxiety, and cognitive functioning. Sleep is increasingly recognized as a foundational health behaviour comparable to diet and exercise.

Diagnosis often requires multi-component assessment: clinical interview, sleep diary, sleep questionnaires (PSQI, Insomnia Severity Index, Epworth Sleepiness Scale, STOP-BANG), and in many cases polysomnography (overnight sleep study) to evaluate for sleep apnea, narcolepsy, REM behaviour disorder, or other conditions requiring objective sleep measurement.

Treatment is highly effective. First-line treatments are evidence-based behavioural and lifestyle interventions; pharmacotherapy is appropriate for some conditions but not first-line for chronic insomnia. CPAP for sleep apnea, appropriate medications for narcolepsy and restless legs, and CBT-I for insomnia all produce substantial improvements with sustained benefit.

Signs and symptoms

Difficulty initiating sleep — Sustained difficulty falling asleep at desired bedtime; sleep latency exceeding 30 minutes on most nights.
Difficulty maintaining sleep — Frequent night-time waking; difficulty returning to sleep after waking; total wake time during the night exceeding 30 minutes.
Early morning waking — Waking earlier than desired and unable to return to sleep; common in major depressive disorder and in older adults.
Non-restorative sleep — Adequate hours of sleep that does not produce a feeling of restoration; persistent fatigue despite normal-appearing sleep.
Excessive daytime sleepiness — Persistent sleepiness during waking hours; difficulty staying awake in passive situations; characteristic of hypersomnia, narcolepsy, and untreated sleep apnea.
Loud snoring with breathing pauses — Witnessed apneic episodes, gasping or choking arousals, loud snoring — characteristic features of obstructive sleep apnea.
Cataplexy and sleep attacks — Sudden brief loss of muscle tone (often triggered by emotion) and sudden involuntary sleep onset — characteristic features of narcolepsy.
Restless legs and limb movements — Uncomfortable urge to move the legs, particularly in the evening; relieved by movement; often disrupts sleep onset.
Recurrent nightmares — Persistent distressing dreams causing waking; trauma-related nightmares are particularly common in PTSD.
Functional impairment — Daytime fatigue, mood changes, cognitive impairment, work or school difficulties, increased accident risk attributable to sleep disturbance.

Diagnostic context

The DSM-5-TR includes ten Sleep-Wake Disorders. Brief criteria for the most commonly encountered conditions:

Insomnia Disorder (780.52): dissatisfaction with sleep quantity or quality with one or more of: difficulty initiating sleep; difficulty maintaining sleep; early-morning waking with inability to return to sleep. Disturbance causes significant distress or impairment, occurs at least 3 nights per week, present for at least 3 months, occurs despite adequate opportunity for sleep, not better explained by another sleep-wake disorder, not attributable to a substance or coexisting medical/mental disorder.

Hypersomnolence Disorder (780.54): excessive sleepiness despite a main sleep period of at least 7 hours, with one or more of: recurrent sleep periods or lapses into sleep within the same day; prolonged main sleep episode; difficulty being fully awake after abrupt awakening. Occurs at least 3 times per week, for at least 3 months, with significant distress or impairment.

Narcolepsy (347.x): recurrent periods of irrepressible need to sleep, lapsing into sleep, or napping occurring within the same day, at least 3 times per week over the past 3 months, with at least one of: cataplexy; hypocretin deficiency on cerebrospinal fluid measurement; nocturnal sleep polysomnography showing REM sleep latency ≤ 15 minutes, or multiple sleep latency test showing mean sleep latency ≤ 8 minutes and 2 or more sleep-onset REM periods.

Obstructive Sleep Apnea Hypopnea (327.23): evidence by polysomnography of at least 5 obstructive apneas or hypopneas per hour of sleep with either nocturnal breathing disturbances (snoring, breathing pauses) or daytime sleepiness/fatigue/non-restorative sleep; OR evidence by polysomnography of at least 15 obstructive apneas or hypopneas per hour of sleep regardless of accompanying symptoms.

Circadian Rhythm Sleep-Wake Disorders: persistent or recurrent pattern of sleep disruption due to alteration of circadian system or misalignment between endogenous rhythm and required sleep-wake schedule. Subtypes include delayed sleep phase, advanced sleep phase, irregular sleep-wake, non-24-hour sleep-wake, shift work, and jet lag types.

Restless Legs Syndrome (333.94): urge to move the legs accompanied by uncomfortable sensations, that begins or worsens during periods of rest, is partially or totally relieved by movement, and is worse in the evening or night. Occurs at least 3 times per week, persisted for at least 3 months, causes significant distress or impairment.

Differential diagnosis often requires polysomnography, multiple sleep latency testing, actigraphy, and sleep diaries. Sleep disorders frequently coexist (e.g., insomnia + sleep apnea + restless legs); accurate identification of all contributing conditions is important.

Causes and risk factors

Sleep disorders develop through varied etiological pathways depending on the specific condition:

Insomnia: typically multi-factorial. Predisposing factors (genetics, female sex, older age, anxiety/depression history), precipitating factors (acute stress, illness, life events), and perpetuating factors (cognitive arousal, conditioned bed-wake associations, behavioural changes that maintain insomnia) all contribute. The Spielman 3P model (predisposing, precipitating, perpetuating) is the dominant clinical framework.

Sleep apnea: obesity, male sex, older age, large neck circumference, family history, alcohol use, sedative use, smoking, and anatomical features (small jaw, large tongue, enlarged tonsils) all contribute. Central sleep apnea has different etiology including heart failure and opioid use.

Narcolepsy: in narcolepsy type 1 (with cataplexy), loss of hypocretin-producing neurons in the lateral hypothalamus (autoimmune mechanism in most cases) is the underlying cause. Strong genetic association (HLA DQB1*06:02). Onset typically adolescent.

Restless legs syndrome: dopaminergic dysfunction; iron deficiency is a major contributor; family history common; secondary causes include pregnancy, end-stage renal disease, certain medications.

Circadian rhythm disorders: shift work, time-zone travel, congenital differences in circadian period, blindness, and adolescent biological tendency toward delayed sleep phase all contribute.

Parasomnias: NREM parasomnias (sleepwalking, sleep terrors) often have family history, are more common in children, and may be precipitated by sleep deprivation or stress. REM behaviour disorder is associated with synucleinopathies (Parkinson disease, Lewy body dementia, multiple system atrophy).

Comorbidity: sleep disorders are bidirectionally related to depression, anxiety disorders, PTSD, ADHD, substance use disorders, chronic pain, cardiovascular disease, type 2 diabetes, and many other conditions. Untreated sleep apnea is associated with elevated cardiovascular and metabolic risk; chronic insomnia is associated with elevated risk of new-onset depression.

Typical treatments

Treatment varies by specific sleep disorder; first-line approaches are typically behavioural and lifestyle-based:

Cognitive behavioural Therapy for Insomnia (CBT-I): first-line treatment for chronic insomnia, recommended above pharmacotherapy by all major guidelines (American College of Physicians, American Academy of Sleep Medicine, NICE). 4-8 session structured protocol including stimulus control, sleep restriction, cognitive restructuring, sleep hygiene, and relaxation. Strong evidence base; effects are typically maintained without ongoing treatment, unlike pharmacotherapy.

Continuous Positive Airway Pressure (CPAP): first-line treatment for moderate-to-severe obstructive sleep apnea. Substantial evidence for symptom resolution and reduction in cardiovascular and metabolic risk. Adherence is the principal challenge; CPAP optimization, mask fit, and behavioural support all matter.

Oral appliances for mild-to-moderate sleep apnea or for CPAP-intolerant individuals.

Pharmacotherapy for narcolepsy: stimulants (modafinil, armodafinil, methylphenidate, amphetamine), sodium oxybate (for cataplexy and excessive daytime sleepiness), pitolisant, and solriamfetol. Treatment is typically lifelong.

Pharmacotherapy for restless legs syndrome: dopaminergic agents (pramipexole, ropinirole, rotigotine), gabapentin enacarbil and other gabapentinoids, iron supplementation when deficient. Augmentation (worsening with treatment) is a common long-term complication of dopaminergic agents.

Pharmacotherapy for insomnia: not first-line. When used, options include melatonin agonists (ramelteon), DORA medications (suvorexant, lemborexant), low-dose doxepin, and short-term benzodiazepine receptor agonists (zolpidem, eszopiclone — short-term only). Benzodiazepines are typically avoided long-term due to dependence and tolerance.

Light therapy and chronotherapy for circadian rhythm disorders. Bright light at strategic times can phase-advance or phase-delay the circadian system. Melatonin (low-dose) at strategic times can also shift circadian phase.

Sleep hygiene — regular schedule, limited caffeine and alcohol, comfortable sleep environment, screen reduction before bed — is foundational but rarely sufficient alone for clinical sleep disorders.

Treatment of comorbid conditions: depression, anxiety, PTSD, chronic pain, and substance use disorders all worsen sleep; treating these often improves sleep concurrently. Conversely, treating sleep disorders frequently improves comorbid mental-health and physical-health conditions.

When to seek help

Professional evaluation is indicated when:

Sleep difficulties have persisted at least 3 nights per week for 3 or more months.
You are experiencing significant daytime fatigue, mood changes, or cognitive impairment attributable to sleep.
You snore loudly, gasp or choke during sleep, or have been told you stop breathing during sleep.
You experience excessive daytime sleepiness, sudden sleep attacks, or sudden brief loss of muscle tone with emotion.
You have uncomfortable urges to move your legs at night that interfere with sleep onset.
You have trouble adjusting to a shift-work schedule or significant time-zone change.
Sleep difficulties co-occur with depression, anxiety, PTSD, or substance use.
You have been using sleep medications regularly and want to reduce or discontinue them.

If you have suicidal thoughts or sleep disruption is part of severe depressive or anxiety symptoms, free 24-hour support is available across Canada at 9-8-8 (Suicide Crisis Helpline) or 1-833-456-4566 (Talk Suicide Canada).

Frequently asked questions

Is insomnia a real medical condition?

Yes. Insomnia Disorder is a formally defined DSM-5-TR diagnosis (780.52) with specific criteria, robust prevalence data, and an established treatment evidence base. It is one of the most common sleep disorders and is associated with substantial functional impairment and elevated risk for other mental and physical health conditions.

Should I just take a sleeping pill?

Not as first-line treatment for chronic insomnia. All major clinical guidelines recommend Cognitive behavioural Therapy for Insomnia (CBT-I) as first-line. CBT-I has stronger long-term outcomes than medication, no dependence risk, and effects that persist after treatment ends. Medications have a role for short-term use or when CBT-I is unavailable or insufficient.

How do I know if I have sleep apnea?

Common signs include loud snoring, witnessed breathing pauses, gasping or choking arousals, morning headaches, dry mouth, daytime fatigue, and difficulty concentrating. Risk factors include obesity, male sex, older age, large neck circumference, and family history. Validated questionnaires (STOP-BANG, Epworth Sleepiness Scale) screen for elevated risk; diagnosis requires polysomnography (overnight sleep study).

Why am I always tired even though I sleep enough hours?

Several possibilities: undiagnosed sleep apnea (very common), poor sleep quality (frequent brief arousals), other sleep disorders, depression, thyroid dysfunction, anemia, vitamin deficiency, chronic fatigue syndrome, or other medical conditions. Comprehensive evaluation including sleep assessment is appropriate.

Are 8 hours of sleep necessary?

Adult sleep needs vary; most adults need 7-9 hours. Short sleepers (consistently 5-6 hours without daytime impairment) and long sleepers (consistently 9-10 hours) exist as natural variants. The functional measure — daytime alertness, mood, and cognition — is more important than the hour count.

Is napping bad?

Not inherently. Brief naps (10-20 minutes, before mid-afternoon) can be restorative and do not typically disrupt nighttime sleep in healthy sleepers. Long naps, late naps, or naps used to compensate for chronic sleep deprivation may worsen insomnia. For people with chronic insomnia, napping is typically discouraged.

References

American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.). APA.
American Academy of Sleep Medicine. (2014). International Classification of Sleep Disorders (3rd ed.). AASM.
Qaseem, A., et al. (2016). Management of chronic insomnia disorder in adults: A clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 165(2), 125–133.
Riemann, D., et al. (2017). European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research, 26(6), 675–700.
Patil, S. P., et al. (2019). Treatment of adult obstructive sleep apnea with positive airway pressure: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 15(2), 335–343.

Find a ShiftGrit therapist for Sleep Disorder

Pick a city to see ShiftGrit clinicians who treat this.

Location

Specialty

Find the pattern behind what's been feeling hard

A few simple questions to help surface the concerns that may fit best.

Find Your Pattern

Find a Therapist by City

Browse therapy availability by city to see local and virtual options, explore services, and connect with a clinician who can serve your area.

Sleep Disorder therapists in Calgary Sleep Disorder therapists in Edmonton Sleep Disorder therapists in Toronto Sleep Disorder therapists in Vancouver

Find a Therapist by Province

Browse therapy options by province to see which clinicians are available to work with clients in your region.

Sleep Disorder therapists in Alberta Sleep Disorder therapists in Ontario

Trusted by Leading Psychology & Mental Health Organizations Across Canada

ShiftGrit Psychology & Counselling is professionally regulated, certified, and recognized by leading psychology and mental-health organizations across Canada. These associations reflect our commitment to ethical practice, clinical standards, and evidence-informed therapy through Identity-Level Therapy and Reconditioning.

Trusted By Alberta’s Leading Psychology & Mental Health Organizations

ShiftGrit Psychology & Counselling is professionally regulated, certified, and recognized by leading psychology and mental-health organizations across Alberta and Canada. These associations reflect our commitment to ethical practice, clinical standards, and evidence-informed therapy through Identity-Level Therapy and Reconditioning.

Regulated and affiliated across Alberta’s leading psychology, counselling, and mental-health organizations.

Regulated and affiliated across Canada’s leading psychology, counselling, and mental-health organizations.

Authored by

ShiftGrit Clinical Editorial Team

The ShiftGrit Clinical Editorial Team combines the insight of registered psychologists, provisional psychologists, and trained writers to create accessible, evidence-informed therapy resources. All content is clinically reviewed by a Registered Psychologist.